Anaplasma phagocytophilum modulates gp91phox gene expression through altered interferon regulatory factor 1 and PU.1 levels and binding of CCAAT displacement protein

Infection and Immunity

Volumn 73, Issue 1, 2005, Pages 208-218

  Thomas, Venetta ^a   Samanta, Swapna ^a   Wu, Caiyun ^a   Berliner, Nancy ^a   Fikrig, Erol ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CCAAT DISPLACEMENT PROTEIN; COMPLEMENTARY DNA; CYTOKINE; GAMMA INTERFERON; GLYCOPROTEIN GP 91; INTERFERON REGULATORY FACTOR 1; MESSENGER RNA; PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STAT1 PROTEIN; TRANSCRIPTION FACTOR PU 1; UNCLASSIFIED DRUG;

ANAPLASMA PHAGOCYTOPHILUM; ARTICLE; BINDING SITE; CELL STRAIN HL 60; CHROMATIN; CONTROLLED STUDY; EHRLICHIOSIS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANAPLASMA PHAGOCYTOPHILUM; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HL-60 CELLS; HOMEODOMAIN PROTEINS; HUMANS; INTERFERON REGULATORY FACTOR-1; MEMBRANE GLYCOPROTEINS; NADPH OXIDASE; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

EID: 11144286429     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.1.208-218.2005     Document Type: Article

References (55)

1. Anderson, K., K. Smith, F. Pio, B. Torbett, and R. Maki. 1998. Neutrophils deficient in PU.1 do not terminally differentiate or become functionally competent. Blood 92:1576-1585.
2. Babior, B. M. 1999. NADPH oxidase: an update. Blood 93:1464-1476.
3. Bakken, J. S., and J. S. Dumler. 2001. Proper nomenclature for the human granulocytic ehrlichiosis agent. Emerg. Infect. Dis. 7:486.
4. Banerjee, R., J. Anguita, D. Roos, and E. Fikrig. 2000. Infection by the agent of human granulocytic ehrlichiosis prevents the respiratory burst by down-regulating gp91phox. J. Immunol. 164:3946-3949.
5. Carlyon, J., W. Chan, J. Galan, D. Roos, and E. Fikrig. 2002. Repression of rac2 mRNA expression by Anaplasma phagocytophila is essential to the inhibition of superoxide production and bacterial proliferation. J. Immunol. 169:7009-7018.
6. Catt, D., S. Hawkins, A. Roman, W. Luo, and D. G. Skalnik. 1999. Overexpression of CCAAT displacement protein represses the promiscuously active proximal gp91(phox) promoter. Blood 94:3151-3160.
7. Coccia, E. M., E. Stellacci, R. Orsatti, E. Benedetti, E. Giacomini, G. Marziali, B. C. Valdez, and A. Battistini. 2002. Protein inhibitor of activated signal transducer and activator of transcription (STAT)-1 (PIAS-1) regulates the IFN-gamma response in macrophage cell lines. Cell Signal. 14:537-545.
8. Condino-Neto, A., and P. E. Newburger. 2000. Interferon-gamma improves splicing efficiency of CYBB gene transcripts in an interferon-responsive variant of chronic granulomatous disease due to a splice site consensus region mutation. Blood 95:3548-3554.
9. Curnutte, J. T. 1993. Chronic granulomatous disease: the solving of a clinical riddle at the molecular level. Clin. Immunol. Immunopathol. 67:S2-15.
10. Decker, T., P. Kovarik, and A. Meinke. 1997. GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J. Interferon. Cytokine Res. 17:121-134.
11. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
12. DiPietrtantonio, A., T. Hsieh, and J. Wu. 2000. Specific processing of poly-(ADP-ribose) polymerase, accompanied by activation of caspase-3 and elevation/reduction of ceramide/hydrogen peroxide levels, during induction of apoptosis in host HL-60 cells infected with the human granulocytic ehrlichiosis (HGE) agent. IUBMB Life 49:49-55.
13. Dusi, S., M. Donini, D. Lissandrini, P. Mazzi, V. D. Bianca, and F. Rossi. 2001. Mechanisms of expression of NADPH oxidase components in human cultured monocytes: role of cytokines and transcriptional regulators involved. Eur. J. Immunol. 31:929-938.
14. Eklund, E., A. Javala, and R. Kakar. 2000. Tyrosine phosphorylation of HoxA10 decreases DNA binding and transcriptional repression during interferon gamma-induced differentiation of myeloid cell lines. J. Biol. Chem. 275:20117-20126.
15. Eklund, E. A., A. Jalava, and R. Kakar. 1998. PU. 1, interferon regulatory factor 1, and interferon consensus sequence-binding protein cooperate to increase gp91(phox) expression. J. Biol. Chem. 273:13957-13965.
16. Eklund, E. A., and R. Kakar. 1999. Recruitment of CREB-binding protein by PU. 1, IFN-regulatory factor-1, and the IFN consensus sequence-binding protein is necessary for IFN-gamma-induced p67phox and gp91phox expression. J. Immunol. 163:6095-6105.
17. Eklund, E. A., and D. G. Skalnik. 1995. Characterization of a gp91-phox promoter element that is required for interferon gamma-induced transcription. J. Biol. Chem. 270:8267-8273.
18. Hawkins, S. M., T. Kohwi-Shigematsu, and D. G. Skalnik. 2001. The matrix attachment region-binding protein SATB1 interacts with multiple elements within the gp91phox promoter and is down-regulated during myeloid differentiation. J. Biol. Chem. 276:44472-44480.
19. Heyworth, P. G., B. P. Bohl, G. M. Bokoch, and J. T. Curnutte. 1994. Rac translocates independently of the neutrophil NADPH oxidase components p47phox and p67phox. Evidence for its interaction with flavocytochrome b558. J. Biol. Chem. 269:30749-30752.
20. Hsieh, T., M. Aguero-Rosenfeld, J. Wu, C. Ng, N. Papanikolaou, S. Verde, I. Schwartz, J. Pizzolo, M. Melamed, H. Horowitz, R. Nadelman, and G. Wormser. 1997. Cellular changes and induction of apoptosis in human promyelocytic HL-60 cells infected with the agent of human granulocytic ehrlichiosis (HGE). Biochem. Biophys. Res. Commun. 232:298-303.
21. Ijdo, J. W., W. Sun, Y. Zhang, L. A. Magnarelli, and E. Fikrig. 1998. Cloning of the gene encoding the 44-kilodalton antigen of the agent of human granulocytic ehrlichiosis and characterization of the humoral response. Infect. Immun. 66:3264-3269.
22. Jacobsen, B., and D. Skalnik. 1999. YY1 binds five cis-elements and transactivates the myeloid cell-restricted gp91phox promoter. J. Biol. Chem. 274:29984-29999.
23. Jones, O. T. 1994. The regulation of superoxide production by the NADPH oxidase of neutrophils and other mammalian cells. Bioessays 16:919-923.
24. Kautz, B., R. Kakar, E. David, and E. A. Eklund. 2001. SHP1 protein tyrosine phosphatase inhibits gp91 phox and p67 phox expression by inhibiting interaction of PU. 1, IRF1, ICSBP and CBP with homologous cis elements in the CYBB and NCF2 genes. J. Biol. Chem. 276:37868-37878.
25. Kelley, T. J., and H. L. Elmer. 2000. In vivo alterations of IFN regulatory factor-1 and PIAS1 protein levels in cystic fibrosis epithelium. J. Clin. Investig. 106:403-410.
26. Khanna-Gupta, A., T. Zibello, S. Kolla, E. J. Neufeld, and N. Berliner. 1997. CCAAT displacement protein (CDP/cut) recognizes a silencer element within the lactoferrin gene promoter. Blood 90:2784-2795.
27. Klein, J. B., J. A. Scherzer, and K. R. McLeish. 1991. Interferon-gamma enhances superoxide production by HL-60 cells stimulated with multiple agonists. J. Interferon Res. 11:69-74.
28. Klein, M. B., J. S. Miller, C. M. Nelson, and J. L. Goodman. 1997. Primary bone marrow progenitors of both granulocytic and monocytic lineages are susceptible to infection with the agent of human granulocytic ehrlichiosis. J. Infect. Dis. 176:1405-1409.
29. Klein, M. B., C. M. Nelson, and J. L. Goodman. 1997. Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins. Antimicrob. Agents Chemother. 41:76-79.
30. Kumatori, A., D. Yang, S. Suzuki, and M. Nakamura. 2002. Cooperation of STAT-1 and IRF-1 in interferon-gamma-induced transcription of the gp91(phox) gene. J. Biol. Chem. 277:9103-9111.
31. Lee, E., and Y. Rikihisa. 1998. Protein kinase A-mediated inhibition of gamma interferon-induced tyrosine phosphorylation of Janus kinase and latent cytoplasmic transcription factors in human monocytes by Ehrlichia chaffeensis. Infect. Immun. 66:2514-2520.
32. Li, S. L., A. J. Valente, M. Qiang, W. Schlegel, M. Gamez, and R. A. Clark. 2002. Multiple PU. 1 sites cooperate in the regulation of p40(phox) transcription during granulocytic differentiation of myeloid cells. Blood 99:4578-4587.
33. Li, S. L., A. J. Valente, S. J. Zhao, and R. A. Clark. 1997. PU. 1 is essential for p47(phox) promoter activity in myeloid cells. J. Biol. Chem. 272:17802-17809.
34. Lievens, P. M., J. J. Donady, C. Tufarelli, and E. J. Neufeld. 1995. Repressor activity of CCAAT displacement protein in HL-60 myeloid leukemia cells. J. Biol. Chem. 270:12745-12750.
35. Lin, R., and J. Hiscott. 1999. A role for casein kinase II phosphorylation in the regulation of IRF-1 transcriptional activity. Mol. Cell. Biochem. 191:169-180.
36. Liu, B., J. Liao, X. Rao, S. A. Kushner, C. D. Chung, D. D. Chang, and K. Shuai. 1998. Inhibition of Stat1-mediated gene activation by PIAS1. Proc. Natl. Acad. Sci. USA 95:10626-10631.
37. Liu, J., A. Barnett, E. J. Neufeld, and J. P. Dudley. 1999. Homeoproteins CDP and SATB1 interact: potential for tissue-specific regulation. Mol. Cell. Biol. 19:4918-4926.
38. Luo, W., and D. G. Skalnik. 1996. CCAAT displacement protein competes with multiple transcriptional activators for binding to four sites in the proximal gp91phox promoter. J. Biol. Chem. 271:18203-18210.
39. Luo, W., and D. G. Skalnik. 1996. Interferon regulatory factor-2 directs transcription from the gp91phox promoter. J. Biol. Chem. 271:23445-23451.
40. Martin-Soudant, N., J. G. Drachman, K. Kaushansky, and A. Nepveu. 2000. CDP/Cut DNA binding activity is down-modulated in granulocytes, macrophages and erythrocytes but remains elevated in differentiating megakaryocytes. Leukemia 14:863-873.
41. Meischl, C., and D. Roos. 1998. The molecular basis of chronic granulomatous disease. Springer Semin. Immunopathol. 19:417-434.
42. Mori, K., S. Stone, L. Khaodhiar, L. E. Braverman, and W. J. DeVito. 1999. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells. J. Cell. Biochem. 74:211-219.
43. Mott, J., and Y. Rikihisa. 2000. Human granulocytic ehrlichiosis agent inhibits superoxide anion generation by human neutrophils. Infect. Immun. 68:6697-6703.
44. Mott, J., Y. Rikihisa, and S. Tsunawaki. 2002. Effects of Anaplasma phagocytophila on NADPH oxidase components in human neutrophils and HL-60 cells. Infect. Immun. 70:1359-1366.
45. Ogden, N. H., Z. Woldehiwet, and C. A. Hart. 1998. Granulocytic ehrlichiosis: an emerging or rediscovered tick-borne disease? J. Med. Microbiol. 47:475-482.
46. Sharf, R., D. Meraro, A. Azriel, A. M. Thornton, K. Ozato, E. F. Petricoin, A. C. Larner, F. Schaper, H. Hauser, and B. Z. Levi. 1997. Phosphorylation events modulate the ability of interferon consensus sequence binding protein to interact with interferon regulatory factors and to bind DNA. J. Biol. Chem. 272:9785-9792.
47. Skalnik, D. G., D. M. Dorfman, A. S. Perkins, N. A. Jenkins, N. G. Copeland, and S. H. Orkin. 1991. Targeting of transgene expression to monocyte/macrophages by the gp91-phox promoter and consequent histiocytic malignancies. Proc. Natl. Acad. Sci. USA 88:8505-8509.
48. Skalnik, D. G., E. C. Strauss, and S. H. Orkin. 1991. CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox gene promoter. J. Biol. Chem. 266:16736-16744.
49. Suzuki, S., A. Kumatori, I. A. Haagen, Y. Fujii, M. A. Sadat, H. L. Jun, Y. Tsuji, D. Roos, and M. Nakamura. 1998. PU. 1 as an essential activator for the expression of gp91(phox) gene in human peripheral neutrophils, monocytes, and B lymphocytes. Proc. Natl. Acad. Sci. USA 95:6085-6090.
50. Ting, L. M., A. C. Kim, A. Cattamanchi, and J. D. Ernst. 1999. Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. J. Immunol. 163:3898-3906.
51. Valarche, I., J. P. Tissier-Seta, M. R. Hirsch, S. Martinez, C. Goridis, and J. F. Brunet. 1993. The mouse homeodomain protein Phox2 regulates Ncam promoter activity in concert with Cux/CDP and is a putative determinant of neurotransmitter phenotype. Development 119:881-896.
52. Voo, K. S., and D. G. Skalnik. 1999. Elf-1 and PU. 1 induce expression of gp91(phox) via a promoter element mutated in a subset of chronic granulomatous disease patients. Blood 93:3512-3520.
53. Webster, P., IJdo, J. W., L. M. Chicoine, and E. Fikrig. 1998. The agent of Human Granulocytic Ehrlichiosis resides in an endosomal compartment. J. Clin. Investig. 101:1932-1941.
54. Yoshiie, K., H. Y. Kim, J. Mott, and Y. Rikihisa. 2000. Intracellular infection by the human granulocytic ehrlichiosis agent inhibits human neutrophil apoptosis. Infect. Immun. 68:1125-1133.
55. Zhi, N., N. Ohashi, Y. Rikihisa, H. W. Horowitz, G. P. Wormser, and K. Hechemy. 1998. Cloning and expression of the 44-kilodalton major outer membrane protein gene of the human granulocytic ehrlichiosis agent and application of the recombinant protein to serodiagnosis. J. Clin. Microbiol. 36:1666-1673.